A recent Bank of America report written by Merrill Lynch analysts Felix Tran and Haim Israel has found that human life expectancy of over 100 years old is soon to become commonplace as investments and advancements in age-defying technologies are expected to sky rocket, reported the Daily Mail.
The report predicted that over the course of the next decade, death-delaying technology will become a major investment area, taking a market already worth about $110 billion to a whopping $600 billion by 2025.
Among the technologies expected to aid in the extension of life expectancy are in the areas of artificial intelligence, disease treatment, and human genome editing while the technological firms heading the developments include Intuitive Surgical and medical device company Zimmer Biomet.
Additionally, genome sequencing costs have fallen by 99.999 percent since 2003, enabling what the authors refer to as a “new frontier” in which precision medicine will be used to extend life expectancy. They dubbed this revolution “techmanity,” a combination of the words “technology” and “humanity.”
0 comments :
Post a Comment